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Abstract 
Protein structure and dynamics dictate the fundamentals of protein function. For 
example, a structured protein must change its conformation when interacting with various 
ligands. In addition, misfolded or intrinsically disordered proteins (IDPs) oligomerize into 
more structured aggregates or amyloid fibrils. Therefore, the study of protein 
conformations becomes necessary to further understand their cellular functions. By 
monitoring the exchange of backbone amide hydrogens as a measurement of protein 
dynamics, time-resolved hydrogen-deuterium exchange (TR HDX) provides advantages 
in capturing the subtle and transient structural differences over other equilibrium state 
techniques, such as X-ray crystallography and NMR. Using TR HDX together with other 
biophysical techniques, we demonstrate the unfolding of lipocalin 2 (Lcn2) in 
accommodating siderophores. In the second part, we attempt to understand the change 
in aggregation rate corresponding to conformational changes of polyglutamine expansion 
protein, huntingtin exon1 (Httex1).  
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	Chapter One: Introduction 
1.1 Hydrogen/Deuterium exchange mass spectrometry (HDX MS), a tool for 
studying protein structural dynamics 
 
1.1.1 Hydrogen/Deuterium exchange (HDX)  
    HDX is an isotopic exchange reaction in which heavier deuterium replaces labile 
hydrogens. Within a protein, the most common labile hydrogens are located on the 
backbone amide, however side chain S-H and O-H also participate in this process.1 To 
understand the correlation between the rate of deuterium uptake and the structural 
dynamics of a protein, the contributing factors of the HDX rate are critical.2  
The primary sequence effects the reaction rate at the individual amino acid level. For 
example, prolines are less meaningful in an HDX reaction since they do not contain labile 
hydrogens. Additionally, a bulky side chain hinders HDX of its neighbouring amino acids.1 
The secondary structure and hydrogen bond network alter the isotopic exchange rate as 
well. A solvent accessible surface will generally have more deuterium displacement, while 
a rigid hydrogen bond network reduces the exchange event.3,4  
    In addition to these, pH and temperature are the other main factors effecting HDX 
rates.5 Calculated from the average activation energy (17kJ) of HDX, deuterium uptake 
is faster at higher temperatures following a 3-fold-increase per 10˚C rule at room 
temperature.6 Furthermore, because of the nature of the catalytic mechanism, HDX is 
heavily pH-dependent.7 Although the HDX reaction can be acid or base catalyzed, base 
catalysis is dominant at pH 7.8 Initiated by deprotonation at the peptide bond amide, 
deuterium displaces hydrogen via an imine intermediate (Figure 1.1 a). Acid catalysis has 
two possible mechanisms, N-protonation or O-protonation. Tautomerization rearranges 
	 2	
the deuterium to the amide position in an O-protonation situation (Figure 1.1 b, c). The 
water-mediated HDX is slow and usually ignored in the analysis.  
 
Figure 1.1. The mechanisms of acid and base catalyzed HDX reaction. 
The electron transfer of backbone amide HDX via a) base catalysis, b) N-protonated 
acid catalysis, and c) O-protonated acid catalysis.  
 
    Specific HDX rates for single amino acids are measured using unstructured peptides. 
The results demonstrate that the slowest exchange rate of backbone amides occur at pH 
2.5 while other side chain hydrogens have much higher rates.9 Therefore, HDX reactions 
are quenched at pH 2.5 to prevent further deuteration at backbone amides while all side 
	 3	
chains back-exchange into hydrogens. The quenching makes downstream application 
possible by controlling specific deuterium uptake time.  
    HDX has long been used as a bioanalytical tool for probing protein dynamics with 
deuterium uptake levels.5 A two-step mechanism of the HDX reaction explains the 
correlation (Equation 1): 
               (1) 
Proteins naturally exhibit a folding and unfolding equilibrium, however, HDX can only 
occur during the open state of a protein. Therefore, a fast first step makes the exchange 
reaction the rate-determining step. Such kinetics, referred to as EX2, is the most 
commonly observed.10 In EX2 kinetics, the observed HDX rate is the measurement of 
dynamics in the hydrogen bonded network. Nonetheless, protein unfolding ranges from 
milliseconds to minutes to a degree which protein unfolding may be the slowest step in 
the mechanism. In the latter case, referred to as EX1 kinetics, the observed HDX rate is 
limited by the open-close equilibrium of a protein.11 By comparing multiple protein states 
at the same pH, temperature and buffer conditions, the change of protein conformational 
dynamics can be described by HDX rates. 
 
1.1.2 Electrospray Ionization mass spectrometry (ESI MS) coupled HDX 
    HDX is historically coupled with NMR, where single amino acid HDX rates can be 
accurately measured.12 However, in the protein realm, NMR poses challenges in the large 
amount of material required, size restriction and long scanning times lasting more than 
10 hours. Because of the mass increase of isotopic reactions, the amount of deuterium 
incorporation is easily detected by mass spectrometry (MS). Development of the 
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electrospray ionization (ESI) technique enables MS coupled HDX.5 ESI is a soft-ionization 
technique that applies a high voltage to the analyte in a metal capillary, generating 
multiply charged ions.13 Although single amino acid resolution is difficult to obtain, HDX 
MS is a more protein-friendly method for monitoring HDX rates. HDX-ESI-MS has been 
widely adopted in the bioanalytical field as a rapid method to study protein-ligand 
interactions.14–16 
 
1.1.3 Conventional HDX 
    In a typical HDX experiment, a protein sample is labelled with deuterium oxide at pH 7 
for various time points. The reaction is then quenched at 0˚C and pH 2.5. In addition to 
the low pH, the low temperature of the quenching condition further prevents back-
exchange at backbone amides.10 Depending on the application, the downstream 
processes vary. Intact protein can be detected directly by ESI MS for global deuterium 
level analysis. The results are plotted as HDX time versus mass increases. In a global 
HDX set-up, the dynamics at different regions of a protein are averaged so that no site-
specific information is provided (Figure 1.2 top).  
Instead, the quenched protein can be digested into peptides before introduction into 
the mass spectrometer (Figure 1.2 bottom). The peptides are usually separated based 
on hydrophobicity on a C18 column by liquid chromatography (LC). Since only a fraction 
of the peptides are sent into the mass spectrometer at a specific retention time, LC can 
effectively reduce peptide overlap. This bottom-up HDX workflow provides information 
localizing dynamics to different areas of a protein. The representation of local HDX data 
can vary, but they generally focus on the difference of deuterium level between various 
protein states and use 3D structures with a heat map to aid the eye.
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Figure 1.2. Schematic representation of typical HDX workflows. 
After different HDX labelling times and quenching, detection by ESI MS can be 
performed on intact protein (top) or peptides (bottom).  
 
1.1.4 Time-resolved HDX 
The conventional bottom-up workflow is the most widely employed HDX MS technique. 
However, the deuterium exchange time is usually limited to 10 seconds or longer. To 
study subtle or transient changes in protein conformational dynamics, time-resolved (TR) 
HDX with millisecond to second deuterium labelling time scales is more desirable. The 
first TR HDX MS experiment was performed on cytochrome C in 1996. The short reaction 
time was achieved by a quench-flow system, where the deuterium contact time is 
determined by the diameter of the mixing tube and flow rates.17 A more elaborate 
continuous-flow set-up was constructed in the Konermann lab to study partially folded 
myoglobin. In this set-up, the isotopic reaction takes places in a fused-silica capillary, 
where the reaction time is controlled by the volume of the mixing capillary and flow rates.18  
The Wilson lab further modified TR HDX as an online labelling and digestion system 
on a microfluidic device.19 The critical component, a capillary based kinetic mixer, 
	 6	
replaces the mixing capillary in controlling the exchange time (Figure 1.3). The inner 
capillary of the mixer is sealed at the end. A notch, 2 mm away from the end of the inner 
capillary allows protein solution to flow into the outer capillary. The protein solution 
contacts and exchanges with deuterium in the inter-capillary space following the notch. 
Because the HDX time is controlled directly by the volume after the notch, the time of the 
analytes staying in this region determines the reaction time. This can be modified by 
tuning the flow rates and the inner capillary position. After labelling, deuterated protein is 
quenched at pH 2.5 by excess acid. Although the acid quenching happens at room 
temperature, the relatively short time between acid contact and detection is unlikely to 
introduce significant back-exchange. TR HDX can provide global or peptide level 
information depending on whether a protease chamber is connected. Proteases are 
immobilized to agarose beads so that they stay in the chamber.  
    Although TR HDX is an excellent tool for probing weak changes in a protein structure 
at short time scales, the lack of liquid handling from LC poses challenges in digestion 
efficiency and limitations on the buffer choices. In terms of obtaining spatial resolution of 
peptides, ion mobility separation (IMS) fractions peptides based on size and charge 
instead of C18 and hydrophobicity.20 More detailed experimental parameters are 
described in section 2.3.7.  
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Figure 1.3. Schematic overview of TR HDX coupled to ESI MS. 
The protein flows in the inner capillary of the kinetic mixer, and only begins contact with 
deuterium after the notch. The reaction volume can be altered by changing flow rates 
and inner capillary position. The protease chamber is optional for bottom-up peptide 
level analysis only. 
 
1.2 Protein-ligand interactions  
As the end products of most gene expressions, proteins execute diverse functions via 
physical interaction with other molecules, either proteins or small molecules. In this work, 
the term ligands refers to binding partners which form a noncovalent but specific complex 
with their target protein. In any protein-ligand system, the forming and dissociating of the 
complex exists as an equilibrium.21 Equation (2) describes the simplest expression of the 
complex formation of one protein (P) and one ligand (L). The dissociation constant (Kd) 
derived from the equilibrium state is usually used to express the affinity because a low Kd 
(high affinity) requires either a high Kon or a low Koff (Equation 3).22 However, instead of a 
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low Kd, a decrease in the system’s free energy is the true driving force. Based on the 
second law of thermodynamics, enthalpy (H) and entropy (S) collectively decides the 
spontaneity of the reaction (Equation 4). The enthalpy drop is mainly contributed by the 
formation of noncovalent forces, including charge-charge, dipole-dipole, charge-dipole 
interactions, hydrogen bonds, and hydrophobic effects.23 Since the interaction happens 
in a solution, both the water and solvent molecules contribute to the interaction as well. 
Therefore, the system entropy changes are determined by hydration network disturbance 
at the binding surface (∆Ssolv), protein conformational rigidity (∆Sconf) and ligand rotational 
translational freedom (∆Sr/t) (Equation 5).22  
                                                  (2) 
                                            (3) 
∆G = ∆H - T∆S                                                    (4) 
∆S = ∆Ssolv + ∆Sconf + ∆Sr/t                                                (5) 
    Theories explaining protein-ligand interactions have evolved over a century following 
the first lock-and-key model. Together with two other popular models, induced-fit and 
conformational selection, the true mechanism governing this interaction is still under 
debate. The original lock-and-key model assumes a rigid protein structure so that only a 
ligand with the correct shape will fit in.24 This theory has been gradually disproven 
because many proteins change their shapes in order to accommodate their ligands.25 The 
induced-fit model hypothesizes that the initial engagement of the ligand is strong enough 
to change the protein into a favourable conformation to form the complex.26 In this model, 
the protein only has one fixed structure before the ligand changes it into a more desirable 
	 9	
conformation. Finally, originating from the protein folding energy landscape theory, 
conformational selection believes that the protein has many pre-existing conformers at 
individual local energy minima (Figure 1.4b).27,28 The association of ligands stabilizes one 
of these conformations and shifts the population towards a single dominant species. Most 
recently, induced-fit has been considered as an extreme case of conformational selection 
where a smooth energy funnel produces only a single dominant conformer (Figure 
1.4a).28  
 
Figure 1.4. The free energy funnel of protein folding. 
The free energy funnels show how unfolded proteins at the top of the funnel fold into 
their native states (N) at a lower energy. (A) The smooth funnel leads to a single native 
state, while (B) the landscaped funnel has multiple energy minima near the native state. 
This figure is adapted from Liu et al.27 
 
1.3 Protein folding and aggregation 
Other than the physical interaction itself, a correct protein structure is also critical for 
protein function.29,30 Protein sequences are selected by evolution to favour correct folding 
	 10	
into a low energy "native state".31,32 Immediately after proteins are synthesized by 
ribosomes, they start to fold with the help of isomerases and chaperones. Isomerases 
facilitate the cis/trans conversion of the peptide bond at prolines and disulphide bond 
formation at cysteines.33,34 At the same time, chaperones work in a chain to provide an 
optimal folding environment and help to sequester the hydrophobic regions.35 
Although the majority of proteins follow the energy down the folding funnel into its native 
state, it can get caught in other local minima or even in a misfolded state (Figure 1.5). 
Under certain circumstances, the misfolded protein can unfold and refold with the aid of 
chaperones.36,37 Failure in reaching the native state despite the help from chaperones, 
misfolded proteins are subject to ubiquitination and proteasome degradation.38 However, 
failure in regulation can cause misfolded proteins to fall into the aggregation funnel 
(Figure 1.5).39  
Alternatively, intrinsically disordered proteins (IDPs) and proteins with intrinsically 
disordered regions (IDRs) function at the edge of the aggregation funnel due to the 
absence of stable native structures.40 In these cases, the exposed hydrophobic regions 
are aggregation-prone (Figure 1.6). Despite the danger of falling into the aggregation 
funnel, normal functions of IDPs are essential.41,42 Additionally, proteins with IDRs play 
essential roles in cellular interactions, such as DNA recognition by the basic leucine-
zipper transcriptional factors.43,44  
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Figure 1.5. Protein folding, misfolding and aggregation. 
Most proteins fold into their native states. Occasionally generated misfolded proteins are 
regulated by chaperone refolding or ubiquitin-proteasome degradation. The dysregulation 
of aberrant folding leads to oligomerization and aggregation. Intrinsically disordered 
proteins (IDPs), at a similar energy regime as misfolded proteins, head to a fibrilization 
pathway when controlled degradation fails. 
	 12	
 
Figure 1.6. The interconnection between folding and aggregation funnels of a 
partially unfolded protein or IDP. 
Proteins partially unfold to carry out part of their function. However, when hydrophobic 
sequences are exposed, IDPs and proteins with IDRs are prone to aggregate. The folding 
funnel has a rough landscape and multiple low energy native states (left), while the 
aggregation funnel has a single metastable fibril state (right). 
 
 
Figure 1.7. A typical aggregation pathway for amyloidogenic proteins. 
Before critical size nucleation occurs, amyloidogenic proteins have a long lag phase. The 
elongation phase involving the addition of monomers is rapid. Once fibrils are formed, the 
extremely stable structure prevents any spontaneous dissociation. 
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In the fibril forming pathway of many amyloidogenic IDPs, a lag phase could last 
months before oligomers exceed a critical size.45 The accumulation of seeding nuclei 
reaching critical size in the lag phase promotes a steep increase in the aggregate sizes 
in the elongation phase, where monomers are added to the oligomer nucleus. Eventually, 
extremely stable amyloid fibrils are formed (Figure 1.7).46 Due to the seeding effect at the 
beginning of the elongation phase, amyloidogenic proteins can act as prions to 
exaggerate other protein oligomerizations. When IDP oligomers above a critical size get 
transported to other cells, they may accelerate the aggregation of other proteins at the 
edge of the aggregation funnel.47 
 
1.4 Research Objective 
    Protein dynamics and structure are critical to carrying out specific functions in the cell. 
Layering a detailed picture of conformational dynamics over known protein structures can 
therefore provide unprecedented insights into the molecular origins of protein function. In 
Chapter 2, our aim is to better understand the unusual interaction between lcn2 and its 
siderophore targets, in the context of bacterial infection and sterile inflammation. In 
chapter 3, we attempt to study the change in aggregation properties from normal to 
mutant transition in huntingtin exon 1 (Httex1). 
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Chapter Two: Change in the conformational dynamics of lipocalin 2 (Lcn2) upon 
siderophore binding 
This chapter is currently being prepared as a manuscript. 
 
2.1 Summary 
    The protein-ligand interaction is modelled by lipocalin 2 (Lcn2) and siderophores. The 
small molecules, siderophores, are produced mainly by bacteria in need of scavenging 
finite amounts of iron from the environment. Bacteria in the gastrointestinal tract use 
enterobactin (Ent) for iron acquisition, while Lcn2 sequesters Ent as a host regulation 
strategy on gut microbiota. Other Lcn2 functions have been actively explored in 
inflammatory conditions, including its manipulation of reactive oxygen species (ROS) 
accumulation and cytotoxicity. The diverse functions of Lcn2 involve the interaction or the 
absence of siderophores. Therefore, studying Lcn2-siderophore complexes contributes 
to the understanding of the releasing mechanism and siderophore selectivity. 
Implementing isothermal titration calorimetry (ITC), hydrogen-deuterium exchange (HDX), 
and native electrospray ionization mass spectrometry (ESI MS), we confirm the 
conformational shift to a more unfolded structure upon siderophore binding. Ferric 2,3-
DHBA-Lcn2 is the most dynamic in its structure and readily releases siderophore 
intracellularly. Ferric Ent-Lcn2 with a less flexible structure, is less susceptible to gas-
phase unfolding and dissociation. An intermediate affinity interaction between Ent and 
Lcn2 unfolds the protein as well. 
  
	 15	
2.2 Introduction 
2.2.1 Gut microbiota symbiosis and bacterial siderophores 
In recent decades, the presence of microbiota in the gastrointestinal tract has been 
recognized as a large contributing factor toward human health and overall homeostasis.48 
Together with resident and transient bacteria, the total number of microbes are estimated 
to be in the same order of magnitude as human cells, with a biomass of around 0.2kg.49 
The microbes are actively engaged in symbiosis with the host so that both organisms gain 
advantages in this relationship. Research shows that mice grown in a sterile environment 
(germ-free mice) have metabolic and immune defects.50,51 More in-depth studies reveal 
this bi-directional interaction cross a single layer of gut epithelial cells. In this symbiotic 
process, microbes utilize plant polysaccharides that are otherwise useless to humans to 
synthesize essential amino acids (arginine and glutamine) and vitamin K for the host.52,53 
Other benefits of gut microbiota include the prevention of colonization of pathogens 
through secretion of various bacitracin, a type of antibiotic produced by bacteria, to inhibit 
growth or kill pathogenic bacteria.54,55  
Despite flourishing of a large gut microbe population, the gastrointestinal tract can be 
considered as a rather hostile environment, in which microbes need to constantly 
scavenge for nutrients and evade the host immune system. Generally, the host immune 
system is designed to eliminate all non-self, but the resident microbes have trained the 
immune system to tolerate their colonization at an early stage of the development.56 The 
remaining challenge becomes how to survive with limited local metal availability, 
especially iron. To acquire enough iron for DNA replication and protein cofactors, bacteria 
implement various siderophores, specialized in chelating iron at high affinities.57 Upon 
secretion, siderophores scavenge iron and transport it back to the bacteria.58,59 
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2.2.2 Enterobactin and its bidentate intermediate 
Grouped based on their functional groups, the three major types of siderophores are 
carboxylates, hydroxamates, and catecholates (Figure 2.1). At physiological pH, the 
deprotonated carboxyl or hydroxyl groups coordinate and capture iron. Multiple functional 
groups can coexist in a single siderophore to enhance iron affinity. Siderophores that 
consist of more than one type of functional group are categorized as mixed type.60 
Enterobactin (Ent), with the highest known affinity towards iron (Kd = 10-52 M), is utilized 
by both common enteric and pathogenic bacteria.61 The strong interaction with iron comes 
from three identical catecholate units.62 Starting with chorismic acid converting into 2,3-
dihydroxybenzoic acid (DHBA), this first step of the enterobactin biosynthesis pathway is 
catalyzed by enzymes EntB, EntC and EntA. Followed by EntE and EntF, three 2,3-DHBA 
are then attached to three L-serine and linked together through serine internal cyclization 
(Figure 2.2).63,64 The hydroxyl oxygen atoms are aligned with the amide proton facing 
outwards at physiological pH. This orientation favors the binding of iron at the hydroxyl 
groups. Upon binding, subsequent deprotonation and peptide bond rotation, iron is fully 
encapsulated by a hexadentate metal cage formed at the centre (Figure 2.3a).65 Although 
the binding affinity is substantially weaker, the intermediate 2,3-DHBA is identified to be 
a siderophore as well.66 According to previous studies, the complex 3[2,3-DHBA]Fe is 
predicted to form a similar iron cage (Figure 2.3b).67 
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Figure 2.1. Functional groups of the three major types of siderophores. 
Iron interacts with siderophores at the deprotonated oxygens in different functional groups. 
Multiple functional groups or multiple types can cooperate in a single siderophore 
molecule. 
 
 
Figure 2.2. The biosynthesis pathway of enterobactin. 
In E. coli, enterobactin is synthesized by a group of five enzymes. For simplification, only 
one intermediate is shown in the pathway. The L-serine is attached to 2,3-DHBA through 
a peptide bond at the carboxyl group. 
OHO
R
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Figure 2.3. The iron cage of catecholate siderophores. 
The iron cage of (A) enterobactin consists of three catecholate units and six deprotonated 
hydroxyl groups. (B) Three 2,3-DHBA are proposed to form a similar hexadentate iron 
cage based on previously reported results.67 The iron molecules are shown as a brown 
sphere at the centre. 
 
 
2.2.3 Lcn2 battles against iron-stealing bacteria 
Naturally, when bacteria evolve a mechanism to acquire iron, the host develops a 
counteractive strategy against iron stealing. A classic tug-of-war model describes this 
constant battle. While Ent chelates and brings iron back into bacteria through the FepA 
receptor, the host utilizes lipocalin 2 (Lcn2, or siderocalin) as a defence mechanism to 
sequester ferric Ent and prevent bacterial iron acquisition (Figure 2.4).68,69 Not only does 
this stop iron transportation into bacteria, but Lcn2 also helps to internalize ferric 
siderophores into the cells and contributes to host iron homeostasis.70 A recent study 
found that Ent-Fe associates with the ATP synthase subunit α and promotes iron influx 
into the mitochondria (Figure 2.4).71 The interaction between Ent and ATP synthase α 
provides a possible destination after siderophore internalization. However, the detailed 
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releasing mechanism from Lcn2 and whether other siderophores behave in a similar 
manner remains unclear.  
Although Lcn2 is an effective defence protein, it only successfully chelates certain 
siderophores. Lcn2 has a β-barrel with a shallow ligand-binding cavity or calyx.72,73 To 
evade the shallow calyx of Lcn2, bacteria glycosylate Ent into a bulkier salmochelin.74 
Many other structurally distinct siderophores can also deliver iron into bacteria without 
interference from Lcn2.75 
 
 
 
Figure 2.4. Iron tug-of-war between host cells and bacteria. 
The better-understood siderophore, Ent, is used to illustrate the iron tug-of-war. The 
bacteria gain iron via FepA receptor, while host cells rescue iron via Lcn2. The Ent 
pathway is based on E. coli iron uptake. A plausible pathway of increasing intracellular 
iron concentration by Lcn2-siderophore complexes is shown without a detailed 
internalization mechanism. 
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2.2.4 Beyond its antimicrobial role: Lcn2 functions in the absence of infection 
    Other than its antimicrobial function, prolonged elevation of circulating Lcn2 is also 
associated with various diseases and inflammation.76–79 However, the exact pathway of 
how Lcn2 is linked to inflammation is still somewhat vague. Lcn2 appears to prevent 
inflammation by promoting bacterial clearance in inflammatory bowel disease.80 On the 
other hand, seemingly contradictory evidence implies a pro-inflammatory effect of Lcn2 
in low-grade inflammation.81 Under chronic neuroinflammatory conditions, Lcn2 promotes 
inflammation through the TNFα pathway.82 Other evidence in obese and diabetic models 
affirms the pro-inflammatory hypothesis.78,83,84 Promoting inflammation or not, Lcn2 is a 
master regulator in many processes even without infections.77 Because Lcn2 has no iron 
affinity by itself, the mammalian siderophore hypothesis arises. A hydroxylmate 
siderophore with structural similarity to bacterial 2,3-DHBA, 2,5-dihydroxy benzoic acid 
(2,5-DHBA) is the best candidate for a mammalian siderophore.85 Other research has 
argued that the host utilizes siderophores produced by resident gut bacteria, instead of 
synthesizing a specific mammalian siderophore.86  
 
2.2.5 Iron overload and reactive oxygen species (ROS) accumulation 
Combining both anti- and pro-inflammatory functions of Lcn2, a dual role of Lcn2 is 
suggested based on its free (apo-Lcn2) and iron-loaded (holo-Lcn2) forms.70 A recent 
study hypothesizes that apo-Lcn2 prolongs cell survival upon intercellular accumulation, 
but holo-Lcn2 promotes cell death through accumulating ROS.67 Although ROS is 
produced under physiological conditions as a pivotal signalling molecule, excess ROS 
initiates oxidative stress, cytotoxicity, and even apoptosis.87,88 The formation of hydroxide 
radicals, one type of intracellular ROS, is directly catalyzed by iron(II) via Fenton-like 
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chemistry.89 Cells regulate free iron by incorporating it into protein, such as ferritin or other 
heme-containing proteins.90 However, cells overloaded with iron inevitably accumulate 
excess ROS.91 Because Lcn2 traffics iron across the cell membrane, the nature of the 
complex and iron-releasing efficiency are the key features that we aim to investigate. 
 
2.3 Experimental methods 
2.3.1 Lcn2 expression and purification 
2.3.1.1 Apo-Lcn2 expression 
Plasmid pPROEX HTb mLipocalin-2 was received as a dry sample on a Whatman #1 
filter paper from the Wang lab (University of Hong Kong). Filter paper containing DNA 
sample was cut into small pieces and submerged in 100 µl nuclease-free water. The 
solution was vortexed and incubated at room temperature for 5 min before removing the 
filter paper by centrifugation. Plasmid concentration was measured by Nanodrop 2000 
(Thermo Scientific). 
To transform chemically competent BL21(DE3) (NEB# C2527I), 80 ng of reconstituted 
plasmid was added into 50µl of competent cells. The mixture was chilled on ice for 30 min 
before heat shocked at 42˚C for 10 sec. After another 5-minute incubation on ice, 940 µl 
of SOC outgrowth medium (2% vegetable peptone, 0.5% yeast extract, 10 mM NaCl, 
2.5mM KCl, 10 mM MgCl2, 10 mM MgSO4, 20 mM glucose) was added for rapid growth 
at 37˚C for 1 hr with vigorous shaking at 250 rpm. The culture was plated on ampicillin 
(100µg/ml) LB-agar plates and incubated at 37˚C O/N. A single colony was used to 
inoculate a 20 ml culture (LB broth with 100 µg/ml ampicillin) growing at 37˚C O/N. Stock 
bacteria were made by mixing overnight culture and 50% autoclaved glycerol at a 1-to-1 
ratio, and stored at -80˚C. 
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For large scale expression, 5 ml O/N cultures were used to inoculate 500 ml LB broth. 
The bacteria were incubated at 37˚C for 4 hrs with 200 rpm shaking. Afterwards, the 
induction took place under the same conditions for 2 hrs with 1 mM IPTG (1M stock 
concentration). Bacteria were pelleted by centrifugation at 6,000xg for 25 min. The pellet 
was stored at -20˚C for downstream purification. 
 
2.3.1.2 Nickle immobilized metal ion affinity chromatography (Ni-IMAC)  
Induced bacteria pellet was resuspended in 20 ml equilibrium buffer (50 mM NaH2PO4, 
300 mM NaCl, pH 8.0) and lysed by sonication (20% amplitude, 15 sec pulse, 15 sec 
intervals, 5 min). Crude protein was collected in the supernatant by centrifugation at 4˚C, 
18,000 rpm for 40 min. Total protein supernatant was filtered with Acrodisc syringe filters 
(0.45 µm, Pall Corporation). A column with Nickel Sepharose 6 Fast Flow resin (GE 
Healthcare Life Sciences) was prepared by washing with 2 column volumes (CV) of 
ddH2O and 5 CV of IMAC equilibrium buffer. Binding of nickel beads and crude protein 
was initiated by incubation at 4˚C for 30 min. The column was further washed with 20 CV 
of IMAC wash buffer 1 (50 mM NaH2PO4, 300 mM NaCl, 20 mM imidazole, pH 8.0) and 
5 CV of IMAC wash buffer 2 (50 mM NaH2PO4, 300 mM NaCl, 50 mM imidazole, pH 8.0). 
Purified protein was eluted with 6 CV of elution buffer (50 mM NaH2PO4, 300 mM NaCl, 
250 mM imidazole). All flow-through fractions were collected for 12.5% SDS-PAGE 
analysis. 
 
2.3.1.3 Lcn2 concentration and storage 
Purified Lcn2 fractions were pooled together and dialyzed against a total of 8 L 
phosphate saline buffer (1X PBS, 137 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 1.8 mM 
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KH2PO4, pH 7.4) using cellulose dialysis tubing (12 kDa to 14 kDa cut-off, Thermo Fisher 
Scientific). The extinction coefficient was computed to be 31985 M-1 cm-1 by ExPASy 
ProtParam tool. Lcn2 concentration was estimated by OD280 before concentrating with 
Amicon Ultra-15 centrifugal filters (10kDa MW cut-off). Final protein concentration was 
measured by Bradford assay. Lcn2 was stored at a concentration higher than 1 mg/ml in 
1X PBS at -80˚C.  
 
2.3.2 Lcn2-siderophore complex formation  
Stock siderophores 2,3-DHBA and Ent were dissolved in DMSO at concentrations of 
300mM and 15mM respectively. Ratios of Lcn2:2,3-DHBA (1:6) or Lcn2:Ent (1:2) were 
used to form complexes with Lcn2 in the absence of iron. Excess siderophore were used 
to favor the formation of the complex and limit free Lcn2 in the solution. When forming 
holo-Lcn2 complexes, FeCl3 (10 mM in ddH2O) and siderophores were mixed at room 
temperature before introducing Lcn2 into the mixture. Based on preliminary results of 
stoichiometry in the complex, the ratio of 2,3-DHBA:Fe(III) was fixed to 3:1.67 Iron-laden 
[Fe(III)Ent]3- was formed at a 1:1 ratio. All complexes were formed in 1X PBS (pH 7.4) at 
20 µM Lcn2 concentration. The mixture was incubated at room temperature for 30 min. 
Any unbound iron or siderophores were washed away during Zeba spin column desalting 
(Thermo Fisher) prior to MS analysis. 
 
2.3.3 Isothermal Titration Calorimetry (ITC) 
Degassed samples were analyzed by a MicroCal Thermo Vac unit for ITC experiments. 
The titrant, siderophores, in the syringe were injected into a protein solution in the 
thermally controlled cell. The association of Lcn2 and ligand was performed at 20˚C with 
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4 µM protein and 0.08 mM Ent. Although the Ent stock was dissolved in DMSO, the final 
concentration in the cell is only 0.56% (v/v) after dilution with 1X PBS. Higher 
concentrations of protein (20 µM) and 2,3-DHBA (0.3 mM) were used due to the lower 
affinity.92 A final DMSO concentration was calculated to be 0.0267%.  
Lcn2 was freshly dialyzed in 20 ml of 1X PBS prior to  ITC, and the dialyzed buffer was 
used to dilute the siderophore stocks in order to prevent any possible buffer component 
mismatch. The same concentration of DMSO was added to both reference and analyte 
cells for buffer consistency. The titration started by 2 ml injection and 1 min pause, 
followed by 34 subsequences with 300 sec intervals. The first data point was excluded 
from the analysis. The baseline was corrected with the heat of dilution, measured by 
titrating ligands into 1X PBS with the same percentage of DMSO. When applicable, a 
sequential binding model was used to fit and describe the extracted curve.93 
 
2.3.4 Intrinsic fluorescence emission scan 
    Apo-lcn2 or siderophore-siderocalin complexes were prepared at 5 µM in 1X PBS as 
described above. The samples were excited at a wavelength of 280 nm (bandwidth 9 nm). 
The emission fluorescence was measured on a Synergy H4 (BioTek). The emission 
spectra were collected at 2 nm intervals over a 300 to 400 nm range at 22˚C. Results 
were baseline corrected with buffer and siderophore emission spectra.  
 
2.3.5 ESI MS of native and partially-unfolded Lcn2 complexes 
Stock protein was dialyzed into 100mM NH4Ac (pH 6.8) for downstream mass 
spectrometry applications. Both apo-Lcn2 and Lcn2-siderophore complexes were 
identified by ESI MS (Waters Synapt G2-S) with direct infusion at 2 µM protein 
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concentration and 20ul/min flow rate. To unfold the protein, Lcn2 was diluted 10X in 10% 
acetic acid with or without 5% ACN. The instrument was operated in positive ion mode 
with 2.5 kV source voltage and 30V sampling cone. Trap and transfer collision energy 
were set to 15 V and 10 V respectively.  
 
2.3.6 Ion Mobility (IM) MS 
2.3.6.1 Arrival time distribution (ATD) and analysis 
    The tune profile of native ESI-MS was kept the same in the IM MS experiments with 
additional ion mobility conditions. The travelling wave was set to 600 m/s velocity and 
30V height. IMS cell was filled with nitrogen gas flowing at 90 ml/min, giving a pressure 
of 0.319 mbar. The enhanced duty cycle (EDC) delay coefficient was set to 1.41. The 
ATD was the extracted ion mobility chromatogram at a single charge state.  
 
2.3.6.2 Collisional induced unfolding (CIU) and Collisional induced dissociation 
(CID) 
   Identical IM MS settings from section 2.3.6.1 were used for both CIU and CID. The trap 
cell collisional voltage was ramped from 10 V to 80 V. In CIU experiments, the drift time 
is plotted against the trap collisional energy (CE). Intensities are represented by a heat 
map. In CID experiments, changes in mass were monitored with increasing trap CE. The 
intensity damping of the 10+ charge state was graphed against CE. The Boltzmann 
sigmoidal function was used to describe the intensity changes. 
 
2.3.6.3 Collision cross section (CCS) calculation 
In the travelling wave ion mobility system, CCS can only be calculated experimentally 
due to the constantly changing electric field. Three denatured proteins, equine 
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cytochrome C (CytC), horse heart myoglobin and bovine ubiquitin in MeOH:H2O:acetic 
acid (49:49:2) were used as calibrants. The same instrumental conditions were applied 
(section 2.3.6.2) with minimal trap CE at 10 eV. CCS (Ωc) was corrected with literature 
CCS (Ω) from Prof. David Clemmer’s Cross-Section Database (6), where z is the charge 
state, ec is the electron charge in Coulomb, m is the molecular weight of protein calibrant, 
and MN2 is the molecular weight of nitrogen.  
                                                     (6) 
    The drift time was corrected for EDC based on (7). The ln(Ωc) is plotted against ln(td’) 
and fitted to linear regression (8) to find X and A.  
                                                  (7) 
                                                     (8) 
    The td’ is corrected again with experimentally determined exponential factor (X) with 
equation (9). The CCS(Ωunknown) of the target protein is calculated from fit-determined 
constant (A) and td’’ by equation (10). When experimental td is a series of values, this 
sequence of equations can be used to calculate a series of CCS as Y-axis in CIU 
fingerprints.  
                                                   (9) 
                                                        (10) 
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2.3.7 TRESI HDX MS 
2.3.7.1 Protease-agarose bead cross-linking 
To crosslink pepsin from porcine gastric mucosa (Sigma-Aldrich, #P6887) or protease 
XIII from Aspergillus saitoi (Sigma-Aldrich, #P2143) to N-hydroxysuccinimide(NHS) 
activated agarose beads, 20 mg of protease and 50 mg of agarose beads were mixed in 
1 ml ligation buffer (0.1M NaPO4, 0.15M NaCl, pH 5) overnight at 4˚C on an orbital rotator. 
The beads were then washed twice with 1 ml blocking buffer (1M Tris, pH 5). At the end 
of each wash, beads were collected by centrifugation at 2,000xg for 2 min. Subsequently, 
protease beads were incubated in blocking buffer for another 2 hrs at 4˚C with rotation. 
The cross-linked agarose beads were then washed and stored in 10% acetic acid (pH 
2.5). 
 
2.3.7.2 Global HDX data acquisition and analysis  
The microfluidic set-up for HDX experiments was assembled as previously 
described.19,94 Briefly, HDX took place in a capillary-based kinetic mixer, allowing for 
various reaction times. The inner glass capillary (OD 150.8 µm, ID 75.3µm) and outer 
metal capillary (120 mm in length, 28RW, ID 177.8 µM) created a narrow inter-capillary 
space. The quenching acid was delivered with the same sized glass capillary. At the end, 
analyte solution was sent into MS via a metal capillary (33RW, OD 203.2 µM, ID 101.6 
µM). All deuterium, protein, and acid were delivered by syringes pumps (Pump 11 Pico 
Plus Elite, Harvard Apparatus). 
In the global HDX set up, the protein was sprayed directly into the mass spectrometer 
after HDX labelling. Based on flow rates of 5 µl/min protein and 10 µl/min deuterium, 
seven-time points were collected from 0.25 sec to 5.12 sec. Native ESI spectra were 
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taken before labelling and at each time point. The mass increases were determined by 
the deconvoluted mass of each spectrum.  
 
2.3.7.3 Microfluidic device fabrication 
After HDX labelling and acid quenching, the analyte solution was passed through a 
glass capillary (ID 75.3µm) into a poly (methyl methacrylate) (PMMA) microfluidic device 
with immobilized proteases. The microfluidic device was composed of two PMMA 
substrates at dimensions 0.83’’ x 2’’ x 0.25’’, one blank and another with an etched 
protease chamber made using a Versa Laser™ engraver. The two PMMA substrates 
were fused together using acrylic weld.94 
 
2.3.7.4 Data acquisition and analysis for digested workflow of TRESI HDX 
In the bottom-up HDX experiments, the deuterated protein was quenched with 10% 
acetic acid and 5% acetonitrile before online digestion in a PMMA device. A mixture of 
pepsin and protease XIII linked agarose beads at a ratio 1:1 was used in the protease 
chamber. With protein and deuterium flow rates each at 2 µl/min, the HDX reaction times 
were calculated to be 0.68 sec and 3.4 sec at 1 mm and 10 mm inner capillary pull-back 
positions, respectively. Excess acid at a flow rate of 16 µl/min was used to dilute 
deuterium and ensure sufficient quenching.  
Peptide sequences were first searched based on unique mass using the ExPASy 
FindPept tool and confirmed by MS/MS fragmentation. The percentage deuterium uptake 
for each peptide was analyzed in Mass Spec Studio.95 Differences in deuterium uptake 
between the complex and apo-lcn2 were reported. The differences for all time points were 
summed up in the final figure. 
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2.4 Results and Discussion 
2.4.1 Purification of apo-lcn2 
    The pellet after IPTG induction and supernatant following sonication were monitored 
for Lcn2 over-expression levels. The calculated molecular weight from the amino acid 
sequence, 24.2 kDa, positioned apo-Lcn2 around the 25 kDa marker band. A significantly 
thickened band around 25 kDa represented a successful induction. Sonication 
supernatant was hard to interpret due to a large amount of protein present. IMAC wash 
fractions were collected one column volume after each wash buffer was loaded. IMAC 
wash buffer 1 cleaned most of the bacterial proteins. IMAC wash buffer 2 resulted in some 
loss of Lcn2 product, however one column purification was possible with the lower yield. 
A single band around 25 kDa in the 250mM imidazole elution fraction signalled a clean 
Lcn2 product (Figure 2.5). 
 
Figure 2.5. The Ni-IMAC single column purification of Lcn2. 
From left to right, the second and third lanes were pellets before and after induction. The 
fourth lane was sonication supernatant after cell debris removal. Immediately following 
were the flow through of Ni-IMAC, two washes with different imidazole concentrations, 
and elution of the final product. 
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2.4.2 The change in thermodynamic parameters from siderophore interaction 
To study the shifts in system thermodynamics of Lcn2-siderophore complex formation, 
ITC experiments were performed by titrating Ent and 2,3-DHBA into the protein solution. 
Because of the high Kd of ferric Ent, a very low protein concentration was required to 
obtain a reasonable dimensionless sigmoidicity constant (c) according to equation (11), 
where M is the protein concentration and n is the stoichiometry. The association constant 
(Ka) is another expression of affinity, related to Kd by equation (12). Considering the small 
heat released with low concentration, the experiment with ferric Ent was not feasible in 
the current set-up.  
c = Ka x M x n                                                  (11) 
Ka = Kd-1                                                    (12) 
    2,3-DHBA gave an uninterpretable result, with noisy heat release close to the baseline 
(Figure 2.6). The interaction between 2,3-DHBA and Lcn2 was deemed not present at a 
protein concentration of 20 µM. On the other hand, the binding event was clear in the Ent 
Lcn2 pair despite the large error in curve fitting with a sequential binding model. The large 
uncertainty gave a less meaningful value but in the same magnitude Kd1 (1.1 ± 9.7 nM) 
as reported in literature. The biphasic curve was clear evidence for two-event binding, 
where a second event in addition to the initial ligand association changed the system 
enthalpy (Figure 2.7). 
    The second event indicated by the ITC curve has several possibilities, including a 
second binding site,96,97 ligand-induced dimerization,98 or perturbation of protein 
folding/unfolding equilibrium.99,100 As the crystal structure of the human homolog NGAL 
revealed, Lcn2 only has one cup-shaped cavity suitable for Ent.73 Both dimerization and 
unfolding are plausible based on ITC data alone. Since Lcn2 is reported to be both 
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monomeric and dimeric, the possibility of dimerization is examined by native MS ESI 
MS.101 
 
 
Figure 2.6. ITC of 2,3-DHBA and Lcn2 in the absence of iron. 
The heat released from each injection is shown in the top panel. The integrated heat on 
the bottom panel cannot be fit with any known models. Both graphs are corrected with 
the heat of dilution. 
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Figure 2.7. ITC of enterobactin and Lcn2 in the absence of iron. 
Both the heat released per injection (top panel) and the integrated heat (bottom panel) 
are baseline corrected. A sequential binding model is the best in fitting the U-shaped 
curve. The large error in the dissociation constants comes from the low heat and model 
fitting. As a result, enthalpy changes are less accurate despite the seemingly less 
uncertainty. 
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2.4.3 Verification of siderocalin-siderophore complex formation 
    In the absence of iron, siderocalin and siderophore were allowed to interact at twice 
the stoichiometry ratio to form the complex. Two steps were involved in creating a holo-
Lcn2 complex. Iron-chelated ferric enterobactin or ferric 2,3-DHBA always formed first. 
Apo-Lcn2 was then added in the solution to form a ferric complex so that the competition 
between iron-loaded and iron-free siderophore was minimized. Complex formation was 
verified by both intrinsic fluorescence quenching and native ESI MS. 
 
Figure 2.8. Intrinsic fluorescence quenching in Lcn2-siderophore complexes. 
The emission spectrum (n=3) of Lcn2 at 280 nm excitation was collected in the presence 
of siderophores. The spectrum was baseline corrected with buffer and siderophore 
emission. The emissions of Lcn2-Ent and Lcn2-Ent-Fe were similar and overlapping. 
 
According to the amino acid sequence, eleven tyrosines and two tryptophans are 
located in the β barrel of Lcn2. Therefore, ligand binding at the barrel was predicted to 
change the intrinsic fluorescence intensity. Indeed, when Lcn2 was excited at wavelength 
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280 nm, fluorescence quenching was observed for ferric enterobactin, enterobactin and 
ferric 2,3-DHBA (Figure 2.8). In agreement with the ITC experiment, 2,3-DHBA failed to 
produce meaningful intrinsic fluorescence changes above the standard deviation level. 
Enterobactin in both iron-associated and iron-free forms showed similar levels of 
quenching (Figure 2.8). This observation was consistent with literature reported affinities 
at 0.4nM and 4nM for ferric Ent and Ent respectively. 
 
 
Figure 2.9. Native ESI MS of Lcn2 and various siderophores. 
(a) Lcn2 formed complexes with (b) ferric Ent, (c) three 2,3-DHBA with iron, and (d) Ent. 
The absence of a complex peak at higher m/z was shown in Lcn2 mixed with (e) 2,3-
DHBA or (f) 2,5-DHBA. All mixtures were kept at the same protein concentration and 
acquired using identical instrument conditions. The presence of complex peaks was 
consistent in (b)(c)(d) in multiple replicates (n>3), although the ratio between apo-Lcn2 
and bound Lcn2 fluctuated. 
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The formation of Lcn2-Ent and Lcn2-Ent-Fe were clearly indicated by a mass shift in 
ESI MS (Figure 2.9 a,b,d). An increase in mass was also observed with 2,3-DHBA but 
only in the presence of iron (Figure 2.9 c). Repeatedly, 2,3-DHBA alone was unable to 
bind to Lcn2 (Figure 2.9e). The addition of the most popular mammalian siderophore 
candidate, 2,5-DHBA, also did not trigger any complex formation (Figure 2.9f). Relaying 
on the stoichiometry information from ESI MS, both Ent complexes are identified to be at 
a 1:1 association. However, three 2,3-DHBA chelating one iron is bound to Lcn2. Likely, 
six hydroxyl groups from three 2,3-DHBA orient themselves into a hexadentate cage for 
iron, similar to the way Ent chelates iron. The lack of interaction between 2,5-DHBA and 
Lcn2 favours the hypothesis that a specific mammalian siderophore might not exist. 
Instead, the circulating bacterial siderophores are utilized by the host in Lcn2-mediated 
iron homeostasis.86 
In addition to confirming the binding partners for Lcn2, ESI native MS can help verify if 
any dimerization is present. Despite the naturally occurring Lcn2 dimer in vivo, there is 
no evidence of induced dimerization in ESI MS. The low intensity peaks above 3,000 m/z 
were likely artificial (and non-covalent) dimers produced from the ESI source.102 
Therefore, the second event indicated by the ITC measurements is not oligomerization. 
 
2.4.4 Siderophore-siderocalin complex stability  
The stability of the siderocalin-siderophore complexes were investigated using three 
techniques: acid-induced unfolding, collisional induced dissociation (CID), and collisional 
induced unfolding (CIU). During acid-induced unfolding, the protein solution was diluted 
10X into 10% acetic acid to a final pH of 2.5. The same ESI MS parameters were applied 
under acidic conditions. Charge states at lower m/z regions were more intense for 
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siderocalin-siderophore complexes compared to apo-Lcn2. Interestingly, emerging 
charges states preserved the same deconvoluted mass as the original folded species 
(Figure 2.10).  
 
Figure 2.10. The acid induced unfolding of Lcn2 and Lcn2-siderophore complexes. 
The dashed line corresponds to the 15+ charge state of (a) apo-Lcn2 in the unfolded 
charge envelope. The stars mark the same charge state in (b) Lcn2-Ent and (c) Lcn2-2,3-
DHBA-Fe. All unfolded complexes retained their corresponding siderophores, causing a 
shift to a higher m/z than the apo-Lcn2 peak. 
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Unfolded protein is more efficiently protonated and is shifted towards higher charge 
states at a lower m/z range. Therefore, the charge states occurring at the leftmost 
positions represent the most unfolded species that can be detected. The ligand-bound 
peak of this charge state indicates an acid-stable siderocalin-siderophore complex. Most 
likely, acidic conditions alone are not sufficient for siderophore release intracellularly 
without another protein to transfer the iron or siderophore to. 
CID measures mass changes as the complex collides with gas molecules with 
increasing collisional energy (CE). A lower energy required to dissociate the complex is 
translated into a less stable interaction. The Lcn2-Ent complex fully dissociated at a CE 
of 60 eV, marked by a flat intensity change at CE range 60 to 80 eV (Figure 2.11a). For 
ferric Ent, with a higher affinity towards Lcn2, the corresponding complex fully dissociated 
at a CE of 80 eV (Figure 2.11b). All complexes had some unsaturated apo-Lcn2 to start 
with, but only the interaction between 2,3-DHBA and Lcn2 produced intermediates, Lcn2-
[2]2,3-DHBA and Lcn2-[1]2,3-DHBA. The change of intensities for the intermediates 
occurred at CEs of 25 eV and 30 eV, respectively (Figure 2.11c).  
Data points of apo-Lcn2 after a CE of 60 eV are eliminated from Boltzmann sigmoidal 
curve fitting since the decreases in intensities possibly come from the reduced 
transmission efficiency at high CE. Because Lcn2-Ent-Fe dissociation does not plateau 
at a CE of 80 eV, this complex is concluded to have a stronger protein-ligand interaction 
compared to Lcn2-Ent. The stepwise dissociation of Lcn2-2,3-DHBA-Fe reveals that iron 
is only properly chelated with three 2,3-DHBA. Once the first 2,3-DHBA is released, iron 
dissociates as well. 
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Figure 2.11. The collisional induced dissociation of the Lcn2-siderophore 
complexes. 
The intensity shift of the 10+ charge state was monitored. The increased intensities of 
apo-Lcn2 in (a) Lcn2-Ent and (b) Lcn2-Ent-Fe were observed. (c) The step-wise 
dissociation with multiple species was captured in Lcn2-2,3-DHBA-Fe. The two dashed 
lines mark the splitting of forming and dissociation events of Lcn2 together with two 2,3-
DHBA (Lcn2-[2]2,3-DHBA) or one 2,3-DHBA (Lcn2-[1]2,3-DHBA). 
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    While CID measures the tightness of binding between Lcn2 and siderophore, CIU 
measures the readiness of complex unfolding. All drift times were converted into CCS for 
CIU fingerprint plots. A calibration curve with unfolded cytochrome c, myoglobin, and 
ubiquitin is shown in Figure 2.12 with R2 0.99. The conversion was based on the CCS 
database of Prof. David Clemmer. The CIU plot of Lcn2-2,3-DHBA-Fe was not shown 
since the complex dissociated at very low CE. The three major unfolding states of apo-
Lcn2 was compared to both Ent complexes (Figure 2.13a). Lcn2-Ent was more stable at 
both transitions (Figure 2.13b,d). Lcn2-Ent-Fe had a more stable first transition but a 
similar second transition (Figure 2.13c,e). 
 
 
Figure 2.12. The calibration curve of TWIMS with cytochrome C, myoglobin, and 
ubiquitin. 
The detailed calculation of CCS correction was described in section 2.3.6. Charge states 
with multiple conformations were eliminated. ln(Ωcorrected) = x*ln(td’’) + A (A = 1.64x1021 ± 
0.08%, x = 0.587 ± 2.93%). 
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Figure 2.13. The collisional induced unfolding of free Lcn2 complexed with different 
siderophores. 
The gas-phase unfolding (n=2) of (a) apo-Lcn2 had two obvious transitions. The same 
transitions were observed in (b) Lcn2-Ent and (c) Lcn2-Ent-Fe at different CEs. Due to 
the early dissociation of the Lcn2-2,3-DHBA-Fe complex, a CIU fingerprint was not 
generated. The changes in gas-phase unfolding of (d) Lcn2-Ent and (e) Lcn2-Ent-Fe was 
compared to apo-Lcn2. 
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    Taken together, Lcn2-Ent-Fe has a stronger protein-ligand interaction than its iron-free 
counterpart, corresponding to a complex less susceptible to gas-phase unfolding. In the 
gas-phase, the first transition of unfolding at CE 25-30 eV is at the same energy required 
for complex dissociation. The overlapping CE range implies that the dissociation might 
be initiated by unfolding in the gas phase. However, Lcn2 at low pH retains the 
siderophores in its unfolded form in the solution phase. 
 
2.4.5 Global dynamics: ligand-induced Lcn2 unfolding 
To examine the possibility of a shifting folding/unfolding equilibrium by ligand 
association as the second event in ITC, the compactness of the Lcn2 structure was 
investigated by IM-MS arrival time distribution (ATD). The ATD revealed a single 
conformation for the 10+ charge state. A ligand-bound complex showed an increase in 
collisional cross-section with a longer drift time, indicating a reduction in protein 
compactness (Figure 2.14). Due to the direct increase in mass, a positive shift in the CCS 
alone cannot definitively prove unfolding of the protein.  
In terms of the overall hydrogen bond network intactness, all complexes exhibited a 
disruption marked by higher deuterium uptake. The increase of the deuterium level 
possibly came from a ligand-induced conformational switch (Figure 2.15). Although the 
enthalpy usually drops at the binding site via protein-ligand interaction, the averaged 
dynamics cross the whole protein could rise. This increase in structural flexibility has 
previously been shown as a plausible theory with a modified heme ligand.103 
    Possibly because of the higher rotational and translational freedom (Sr/t) presented in 
the catecholate units, Ent without iron has the greatest level of distortion in the protein 
structure. Siderophores with lower degrees of freedom, 2,3-DHBA-Fe and Ent are locked 
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in their shapes by the iron cage. Due to the semi-rigid ferric siderophore conformation, 
the introduction of such siderophores disrupts the Lcn2 structure less.  
   Collectively, the ATD in IM-MS and global HDX rate changes suggest a shift in Lcn2 
folding/unfolding equilibrium towards the less structured state. Therefore, unfolding is the 
perfect candidate for the second event in a biphasic ITC. However, the overall changes 
in protein structure provide limited information on specific changes occurring at the calyx. 
TR HDX experiments are employed to study these local changes in protein structure. 
 
Figure 2.14. ATD of Lcn2 with different siderophores. 
(a) Apo-Lcn2 has a single conformation for the 10+ charge state. Extended drift times 
were observed in (b) Lcn2-Ent, (c) Lcn2-Ent-Fe, and (d) Lcn2-2,3-DHBA-Fe. A reference 
dashed line represents the centroid of apo-Lcn2. 
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Figure 2.15. Global HDX showing variability in conformational dynamics between 
complexes. 
The global changes in deuterium uptake levels were measured at seven different reaction 
times from 0.25 sec to 5.12 sec. The standard deviation was computed from technical 
(n>3) and biological (n≥3) replicates. 
 
2.4.6 Proteolytic digestion optimization  
Due to the acid stability of Lcn2, proteolytic digestion optimization is critical for 
adequate peptide coverage. Four different protease combinations, 100% pepsin, 100% 
protease XIII, 80:20 pepsin:protease XIII, and 50:50 pepsin:protease XIII, were tested. 
The digestion profiles are shown in Figure 2.16. Because the measured deuterium 
exchange level was averaged cross the selected peptide, the shorter peptides were 
preferred to improve the spatial resolution. The lengthy peptide from 100% protease XIII 
digestion was less ideal (Figure 2.16b). The mixture of both proteases at 50:50 gave 
optimal digestion with the highest peptide coverage at 64% (Figure 2.16d).  
    Other than the protease combination, additives in the quenching acid can also help 
with the digestion efficiency. For example, an organic solvent can help unfold the protein 
in addition to acidic conditions alone. Addition of 2% MeOH, or 5% ACN is tested for this 
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purpose. Regarding both unfolding and digestion efficiency, 5% ACN in 10% acetic acid 
was preferred (Figure 2.17). Eventually, the sequence coverage was increased to 73%. 
 
 
Figure 2.16. Optimization of digestion efficiency with four different ratios of 
proteases. 
The ratio of pepsin and protease XIII immobilized agarose beads was altered in the 
protease chamber. (a) 100% pepsin preferably cleaved off the His-tag, leaving the rest of 
the protein poorly digested. (b) 100% protease XIII improved the digestion efficiency, but 
many peptides generated were more than 15 amino acids. (c) Pepsin:protease XIII at a 
8:2 ratio provided no advantage on digestion compared to 100% pepsin. (d) Pepsin: 
protease XIII at a 5:5 ratio was the optimal choice with a suitable peptide amount and 
length. 
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Figure 2.17. Optimization of digestion efficiency via additives in quenching buffer. 
With 10% acetic acid as the quenching solution, (a) 5% ACN partially unfolded Lcn2 in a 
continuous-flow set-up. The digested profile by adding (b) 5% ACN had a more suitable 
peptide diversity and length than (c) 2% MeOH as an additive in the quenching acid. 
 
	 46	
2.4.7 Regions of ligand-induced unfolding revealed by TRESI HDX MS 
The disrupted region on Lcn2 was mapped by TR HDX, a structural technique that is 
sensitive in probing subtle differences between apo-Lcn2 and Lcn2-siderophore 
complexes. The protein was quenched and digested prior to MS analysis, so that the 
deuterium exchanged information was locked to a specific peptide. Difference plots, 
subtracting the complexes’ deuterium uptake with apo-Lcn2, showed overall increases of 
percentage deuterium (and thus increase in dynamics) in red. Lcn2-Ent revealed a wide 
destabilization cross the whole protein, but the largest distortion was localized around the 
binding sites predicted from the human homolog of Lcn2 (Figure 2.18a). A similar region 
of the β barrel was disturbed in Lcn2-Ent-Fe as well (Figure 2.18b). The association with 
ferric 2,3-DHBA displayed a similar but weaker calyx destabilization. The protective effect 
at the 310 helix was undoubtedly more pronounced in Lcn2-2,3-DHBA-Fe (Figure 2.18c). 
    Lower levels of destabilization for Lcn2-2,3-DHBA-Fe conflicts with the global HDX 
results, which suggests that this complex causes the second most pronounced disruption 
in the Lcn2 structure. However, the true deuterium uptake might be higher than what is 
shown in the TR HDX difference plot. Based on the native ESI spectra from section 2.4.3, 
the formation of Lcn2-2,3-DHBA-Fe complex is unsaturated, leaving a substantial amount 
of apo-Lcn2 in the system. The differences are therefore reduced when TR HDX monitors 
the averaged percentage deuterium level of peptides from both species. Ent and ferric 
Ent form more stable complexes with Lcn2 and are skewed towards saturation, so the 
apparent percentage of deuterium uptake is inevitably higher. In this case, global HDX 
provides a more accurate comparison of destabilization between complexes, while TR 
HDX can localize the regions of change in protein structure.  
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Figure 2.18. The difference plots of TR HDX results of multiple Lcn2-siderophore 
complexes. 
The differences between (a) Lcn2-Ent, (b) Lcn2-Ent-Fe, and (c) Lcn2-2,3-DHBA-Fe and 
apo-Lcn2 were averaged from technical replicates (n>3) and summed for biological 
replicates (n=3). The propagated errors of standard deviation were represented by solid 
back lines. Only differences above the errors were identified as significant increases (red) 
or decreases (blue). For easier visualization, the corresponding changes were mapped 
onto a crystal structure (PDB ID: 3S26) on the right. The non-significant regions were 
coloured in gold while grey areas had no sequence coverage. 
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2.5 Conclusion 
    The siderocalin-siderophore interaction displays two-event binding, involving a second 
thermodynamic change other than the initial ligand association. The presence of various 
complexes is verified by native ESI MS and intrinsic fluorescence quenching. Ent-Fe, Ent 
and 2,3-DHBA-Fe are identified as in vitro binding partners. After eliminating the 
possibility of a secondary binding site and dimerization, a ligand-induced protein unfolding 
event is most likely the second thermodynamic change. The unfolding event is further 
confirmed with IM-MS ATD and global HDX results.  
    In-depth analysis via TR HDX reveals that the distortion of the protein structure spreads 
across the whole β-barrel for all complexes at different levels. Lcn2 unfolds to several 
conformers depending on the siderophore, showing greater levels of deuterium uptake 
for Lcn2-Ent to lower levels for Lcn2-Ent-Fe and Lcn2-2,3-DHBA-Fe. Between both Ent 
complexes, Lcn2-Ent is easier to unfold or dissociate in the gas phase. Between both 
ferric ligands, Lcn2-2,3-DHBA-Fe is easier to unfold or dissociate in the gas phase. A cell-
based assay also supports that the easier-dissociated and more unfolded 2,3-DHBA-Fe-
Lcn2 releases its siderophore faster for higher cytotoxicity (Appendix 1, unpublished 
results from collaborator Gary Sweeney). 
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Chapter Three. Studying the aggregation potential of Huntingtin N terminal 
fragment mutants 
3.1 Summary 
    Huntington’s disease (HD) is an inherited genetic disorder caused by mutations in the 
Huntingtin (Htt) protein. The length of the polyglutamine (polyQ) stretch dictates the age 
of onset and the extent to which the individual experiences symptoms. Although the exact 
routine function of Htt is unclear, normal Htt interacts with many other proteins and plays 
a pivotal role in early development.104,105 The limited knowledge regarding its pathology 
suggests that mutant Htt is cleaved into many polyQ-containing N terminal fragments, 
which aggregate into amyloid fibrils and inclusion bodies in the brain.106  
    This study focuses on Htt exon 1 (Httex1), the shortest fragment found in vivo, as a 
model to study the structural transition of the N terminal fragments passing their 
pathological threshold.107 Because of the sharp change in cytotoxicity when exceeding 
39 polyQ, the conformational shift with longer polyQs is thought to contribute to this 
pathological switch. In many pre-existing expression systems, Httex1 is expressed 
together with a solubilisation tag. The first step would be obtaining a more native-like 
conformation via tag removal. Limited analysis has been performed on Httex1 with a short 
polyQ length, but the fast aggregation rate of mutated Httex1 hinders further analysis. 
 
3.2 Introduction 
3.2.1 Huntington’s disease and Huntingtin (Htt) 
While as equally devastating as other neurodegenerative diseases, such as 
Alzheimer's disease and Parkinson's disease, Huntington's disease (HD) is much less 
recognizable due to its low prevalence worldwide. Based on 2016 statistics, 5.96 to 13.7 
per 100,000 people are affected by HD in different regions.108 The low but clustered 
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prevalence can be explained by its inherited pathology. The autosomal dominant mutation 
of Huntingtin (Htt) was identified to be the cause of Huntington's disease in 1993.109,110 
Based on Mendel’s autosomal dominant pattern of inheritance, the descendant of an 
affected parent has 50% probability of displaying symptoms, but the likelihood of 
developing HD without any family history is low.111,112  
The Htt gene contains variable lengths of CAG repeats (Table 1). As the most major 
prognosis factor, CAG repeats higher than 39 are predicted to show symptoms. The 
general population has CAG repeats lower than 35, with a mean length of 26.109,113,114 A 
link has been established between polyQ length and age of onset as well; the longer the 
repeats, the earlier the onset (Table 1).115 Most patients first reveal symptoms in middle 
age after having children, but early onset HD before 20 years old is observed as well 
(juvenile HD). In the most extreme case known, the patient started presenting clinical 
motor manifestation at 18 months.116 No effective treatment is currently available, but 
genetic testing can provide information regarding the likelihood of HD onset based on 
CAG repeat length.  
 
Table 1: A link between CAG repeat length and HD pathology. 
The CAG repeat length determines the poly-glutamine expansion in the Huntingtin protein. 
Based on large surveys and databases, a relationship between phenotype and polyQ 
length has been established. 
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HD patients suffer from both cognitive and motor dysfunctions mainly due to the 
selective death of brain cells. Neuronal cell death at the basal ganglia causes brain mass 
loss and the characteristic erratic movement of HD. As HD progresses, loss of motor 
control inevitably results in the inability to speak and swallow.117,118 Unfortunately, with 
this incurable condition, HD patients resemble healthy individuals pre-symptomatically 
but usually die 15-20 years afterward. The common causes of death are pneumonia and 
heart disease since patients have difficulty synchronizing movements.119,120  
 
3.2.2 Poly glutamine (polyQ) expansion of Htt 
Unusual for a protein of this size, full-length huntingtin protein is 300 kDa but completely 
soluble intracellularly. Htt consists of a polyglutamine (polyQ) stretch with variable lengths 
starting from the eighteenth amino acid from the N terminus, followed are the proline-rich 
region (PRR) and multiple HEAT repeats. The first seventy amino acids (N17), polyQ and 
PRR belong to the Htt exon 1 (Httex1).121 
    Directly coded by CAG repeats, the polyQ expansion has always been the focus of 
research. However, the polyQ motif is not unique to Htt but is present in many other 
disease-causing and essential human proteins.122,123,124 Htt, in its normal or mutant form, 
interacts with over 100 proteins, many via the polyQ region.125 For example, mutant Htt 
has been shown to interact with CREB binding protein (CBP) and decrease transcription 
levels.126,127 Normal functions of Htt are suggested to be in the early development stages 
based on evidence that both homogenous (-/-) and heterogeneous (-/+) Htt knockout mice 
die in the embryonic stage.104,105 However, neither the pathological mechanism nor 
normal pathway is clear for Htt.  
 
	 52	
3.2.3 Htt N terminal fragmentation and Htt exon 1 aggregation 
Despite the little known about Htt, its cleavage-prone property is commonly 
accepted.128,129 Upon protease cleavage, Htt generates many N terminal fragments 
containing a polyQ region. Eventually, those fragments form amyloid-like fibrils and 
inclusion bodies.106 Studies show that the aggregation of N terminal fragments is polyQ 
length dependent, but the length of the fragment is irrelevant.87,130 Implied, only N17 and 
polyQ are involved in the aggregation potential of various mutants. Indeed, N17 changes 
the subcellular localization of N terminal fragments and modulates aggregation through 
post-translational modification and its transient helical property.131,132,133 The structural 
differences between pathological and mutated Htt from simple CAG repeats are believed 
to hold the answer to the sharp change in cytotoxicity.  
 
 
 
Figure 3.1. A schematic representation of the Httex1 constructs. 
A solubilisation tag is attached at the N terminus with a linker, containing a EK specific 
cleavage site. The exon 1 gene has three parts, N terminal 17 amino acid (Nt17), polyQ, 
and a proline-rich region (PRR). The His tag at the C terminus is used for IMAC 
purification. 
 
PolyQ length has been observed to change the helical tendency of the N17 region and 
might regulate the aggregation rate through N17.134 The PRR region following polyQ has 
no significant function in the normal Htt protein, so the aggregation is less likely to be 
controlled by this region.135 Exon 1 (N17, polyQ, and PRR) is the smallest fragment 
observed in vivo, and is readily available as a bacterial construct.107 Httex1 is convenient 
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as a model of the N terminal fragment, however, almost all purification systems for Httex1 
produces a tagged protein for intercellular solubilization purposes. The first step of this 
study will be generating tag-free proteins for more native-like structures. The specific 
constructs used in this work are listed in Figure 3.1. 
 
3.3 Experimental Methods 
3.3.1 Thioredoxin (TrxA) tagged Htt exon 1 induction and expression 
Plasmids with various polyglutamine lengths (pET32a-HD16Q, pET32a-HD25Q, 
pET32a-HD39Q, pET32a-HD46Q) were purchased from Addgene. All plasmids were 
transformed into BL21 cells following the same protocol described in section 2.3.1.1. 
Expression was performed on small volume (100 ml to 200 ml) cultures and pooled 
together into a single pellet for downstream purification. Cultures were grown at 37˚C for 
2 hrs to reach OD600 0.6. Bacteria were induced with 0.7mM IPTG at 18˚C O/N. Induced 
bacteria were pelleted at 6,000 xg for 25min. The pellet was lysed by either osmotic shock 
(OS) or sonication. The OS procedure was adopted from the protocol developed in the 
Bjorkman lab. Briefly, ice cold equilibrium buffer (15 mM Tris, 20% sucrose, pH 8.0) with 
a ¼ volume of the culture was used to resuspend the pellet by gentle swirling and rocking 
at 4˚C for 30 min. The pellet was collected again at 15,000 xg for 30 sec at 4˚C. The 
second resuspension used OS buffer (15 mM Tris, pH 8.0). A 60 min incubation at 4˚C 
with rocking was followed by centrifugation at 15,000 xg for 10min at 4˚C to extract 
peripheral proteins. The supernatant was collected. Sonication was performed with the 
parameters listed in section 2.3.1.2, except 30% amplitude was used. 
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3.3.2 Ni-IMAC purification 
    The first nickel IMAC purification of TrxA-tagged Httex1 used a similar protocol as 
described in section 2.3.1.2 with some minor modifications. The same phosphate based 
buffer system was used, but the washing buffers had concentrations of 20mM, 50mM, 
and 100mM imidazole respectively. Phosphate buffer with 500mM imidazole was used to 
elute a relatively concentrated product, to avoid any further concentration steps. Excess 
imidazole was eliminated by dialyzing into enterokinase (EK) cleavage buffer (50mM 
NaH2PO4, 50mM NaCl, 1mM EDTA pH 6.0). 1 mM EDTA was added to the protein prior 
to dialysis to help prevent aggregation. 
 
3.3.3 TrxA tag cleavage 
    For HD16Q, the lowest aggregation potential variant, the TrxA tag cleavage was 
performed at room temperature (RT) without agitation O/N. Protein concentration was 
estimated by OD280 after dialysis. One IU of light-chain EK (stock concentration at 33 
IU/ml) cleaved 50 µg of protein under these conditions. For HD46Q, the fastest 
aggregating variant, TrxA was cleaved by full-length EK for one hour at RT without 
agitation with the same protein:enzyme ratio. Tag-free Httex1 was immediately diluted to 
at least twice the volume with CIX loading buffer (50mM NaH2PO4, pH 6.0). The dilution 
slowed down the aggregation and lowered the NaCl concentration for downstream CIX. 
 
3.3.4 Cation ion exchange (CIX) chromatography 
    EK-cleaved Httex1 was loaded onto a CIX gravity column pre-equilibrated with CIX 
loading buffer. The column was further washed with CIX wash buffer 1 (50mM NaH2PO4, 
50mM NaCl, pH 6.0) and CIX wash buffer 2 (50mM NaH2PO4, 100mM NaCl, pH 6.0). 
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Purified tag-free Httex1 was eluted with 500mM NaCl (in 50mM NaH2PO4, pH 6.0). All 
purified tag-free Httex1 were pooled together from 1 ml elution fractions. 
 
3.3.5 Htt exon 1 concentration and storage 
    CIX elution buffer was used as the storage buffer for Httex1. All TrxA-Httex1 protein 
after IMAC purification was visualized on 12.5% SDS-PAGE, while EK-cleaved Httex1 
was identified on 15% SDS-PAGE. In both cases, 200 V was applied for 43 min. The 
concentration was estimated using the Bradford assay. Since Httex1 interacts with 
Bradford reagent poorly due to a lack of aromatic residues, results can be less accurate. 
Concentration was not performed because the tag-free sample would easily aggregate in 
the process.  
 
3.3.6 ESI native MS 
The final tag-free products were buffer exchanged using a HiTrap desalting column (5 
ml, GE Healthcare). The column was equilibrated with 5 CV 500mM NH4Ac (pH 6.8) 
before sample loading. The common loading and elution volumes are listed in Table 2. 
Protein at around 3µM flowed at a rate of 20 µl/min into the ESI source. The instrument 
(Waters Synapt G2-S) was operated in positive ion mode with a source voltage of 2.5 kV, 
temperature of 100˚C, and 25 V sampling cone. Mild collision was applied at 10 V and 6 
V for Trap and Transfer cells respectively. The IMS cell operated at 650 m/s wave velocity 
and 40 V wave height. 
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Table 2: The standard loading and elution of a HiTrap desalting column. 
A 5ml HiTrap column can only desalt a maximum of 1.5 ml sample at a time. With enough 
sample available, larger loading volume was always preferable to minimize the dilution. 
 
 
3.3.7 Proteolytic digestion 
    In preparation for TR HDX, different protease combinations (100% protease XIII, 100% 
pepsin, and 50:50 protease XIII:pepsin) were tested for best digestion results. All 
digestions were carried out in the protease chamber, with deuterium substituted with 500 
mM NH4Ac. The quenching acid was 2% formic acid with 1% MeOH. The flow rates were 
3 µl/min for both protein and buffer lines. The acid flow rate was set to be 15µl/min. The 
digestion profile was optimized using HD16Q. 
 
3.4 Results and Discussion 
3.4.1 HD16Q purification 
After O/N induction, the bacterial culture was pelleted for cell lysis. Suggested by the 
purification protocol from the Bjorkman group (the same lab that produced the pET32a-
Httex1 constructs), the pellet was lysed with osmotic shock (OS).136 Because TrxA is 
secreted to the periplasm of E. coli cell, the fusion protein can be released by osmotic 
shock. The yield of osmotic shock was low since most of the TrxA-HD16Q remained in 
the pellet (Figure 3.2). The cell lysis was improved by sonication with 30% amplitude.137 
The lysed protein mixture was loaded onto the IMAC column. The IMAC elution contained 
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many impurities that can be cleaned up further with a second column after the TrxA tag 
is cleaved (Figure 3.3a).  
 
Figure 3.2. HD16Q pellet lysis via osmotic shock. 
The supernatants (S/N) after incubating in equilibrium buffer or osmotic shock (OS) buffer 
were collected. The OS pellet was used to check the lysis efficiency. Bacterial pellet refers 
to the cultured pellet before lysis, dissolved in SDS-PAGE running buffer or 8M urea. The 
same OS protocol was used to extract peripheral proteins after 3 hrs 37˚C induction or 
O/N 18˚C induction. The apparent band at a molecular weight of around 35 kDa was the 
TrxA-HD16Q fusion, overlapping with E. coli proteins. 
 
    Enterokinase (EK), the protease cleaving at a specific site (Asp-Asp-Asp-Asp-Lys) just 
before Httex1, is a heterodimer with light and heavy chains. The light-chain is the catalytic 
subunit.138 TrxA-HD16Q was cleaved with light-chain EK overnight at RT without agitation, 
resulting in around 70% HD16Q product (Figure 3.3b). Httex1 (pI 7.07) can be well 
separated from the other proteins in the mixture, TrxA-Httex1 (pI 5.25), TrxA (pI 4.31) and 
EK (pI 5.20), with cation exchange chromatography (CIX). Both TrxA and EK did not bind 
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to the column, but a small amount of uncleaved TrxA-HD16Q remained in the elution 
(Figure 3.3b).  
 
 
Figure 3.3. Ni-IMAC purification of HD16Q followed by tag removal. 
HD16Q was first purified with (a) Ni-IMAC and the cleaved product was further cleaned 
up with (b) CIX. Ni-IMAC fractions were run on a 12.5% SDS-PAGE while CIX fractions 
were run on a 15% gel. Multiple elution fractions were collected for CIX, but only the first 
four were shown on this gel. The apparent molecular weight was around 20kDa for 
HD16Q (calculated mass of 10.5 kDa). 
 
3.4.2 HD46Q optimization 
    The purification process is different for the constructs with longer polyglutamine 
expansions above the pathological threshold. With the solubilizing tag, TrxA-HD46Q was 
successfully purified by IMAC (Figure D3.4a). However, cleaved HD46Q has a much 
higher aggregation potential, resulting in a large volume of aggregates. The small amount 
of soluble protein leftover was not enough for CIX purification (Figure 3.4b). Further 
optimization of the tag removal time course was performed using only the light-chain EK. 
Light-chain EK had a much lower efficiency because it only cleaved around half of the 
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protein after 6 hrs of RT incubation (Figure 3.5). Longer incubation at RT gave rise to 
aggregates that prevented further cleavage. Incubation at 4˚C had even lower efficiency 
but slowed down the aggregation. This condition only provided around 30% product after 
O/N incubation, despite the absence of visible aggregates (Figure 3.5). 
 
Figure 3.4. Same purification protocol of HD16Q on HD46Q.  
(a) The results of Ni-IMAC were visualized on a 12.5% SDS-PAGE. TrxA-HD46Q was 
successfully purified at an apparent MW of 40 kDa. (b) All fractions of CIX were loaded 
on a 15% SDS-PAGE. Multiple elutions revealed no signs of HD46Q. The dominant band 
between MW 18.4 and 14.4 likely corresponds to the TrxA tag. 
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Figure 3.5. Time-course of light-chain enterokinase (EK) tag removal. 
The incubation with EK was conducted at RT or 4˚C. Samples were collected every hour 
for 6 hrs. The enzymatic reaction was stopped by adding SDS-PAGE loading buffer and 
boiling for 5 min. The agitation of the O/N digestions were kept at a minimum.  
 
Full-length EK was used instead to solve the problem of low efficiency. With the same 
protein to enzyme ratio, full-length EK cleaved TrxA-HD46Q to near completion in one 
hour at RT (Figure 3.6a). The tag-free product was loaded onto CIX, but it associated 
poorly with the column and was lost in the flow through. The final elution only contained 
very diluted protein together with some possibly uncut TrxA-HD46Q (Figure 3.6b). 
Another buffer system (50mM MES, pH 6.0) was tested for CIX as well. However, it 
possessed no advantages regarding EK efficiency or column affinity. 
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Figure 3.6. TrxA tag of HD46Q cleaved by full chain EK. 
The same IMAC protocol was followed for TrxA-Htt46Q purification. After incubation with 
EK at RT, the aggregates were removed by centrifugation and the supernatant was 
loaded onto a CIX column. Fractions of CIX were collected and visualized using 15% 
SDS-PAGE. The apparent masses at 40 kDa and 25 kDa correspond to TrxA-HD46Q 
and HD46Q respectively. 
 
3.4.3 ESI native MS 
Only HD16Q and HD25Q were successfully purified and observed on native ESI MS. 
HD16Q showed two charge state envelopes with charge states ranging from 7+ to 14+ 
(Figure 3.7a). The deconvoluted mass constructed from all charge states was 10,305 Da, 
agreeing with the calculated mass of 10.5 kDa (Figure 3.7b). HD25Q had a similar but 
more distinct two charge state envelope pattern, with a deconvoluted mass of 11,346 Da 
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(11.7 kDa calculated) (Figure 3.7c-d). The wide range of charge states in both variants 
agreed with the unstructured nature of Httex1.  
 
 
Figure 3.7. Native ESI MS spectra of Httex1 below the pathological length of polyQ. 
The (a) HD16Q and (c) HD25Q spectra were deconvoluted by UniDec. The peaks of 
deconvoluted (b) HD16Q and (d) HD25Q were labelled with purple dots. 
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Figure 3.8. The relative drift time distribution of different charge states in HD16Q 
and HD25Q.  
The extracted relative drift time for (a) HD16Q and (b) HD25Q were (c) plotted against 
the charge states. The dashed line separated the partially structured and unfolded charge 
states. 
 
In both HD16Q and HD25Q, the ATD for each charge state was well resolved (Figure 
3.8 a-b). For the unfolded envelope, spanning charges 11+ to 14+, the charge and drift 
time had a linear relationship (Figure 3.8c). In the structured envelope, each charge state 
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had multiple drift times (Figure 3.8c). The two charge envelopes and multiple conformers 
imply that even intrinsically disordered proteins have some partially folded structures. 
When comparing the partially folded species, HD25Q has a shorter drift time despite the 
larger MW. Therefore, the reduced drift time may result from a more compact structure of 
HD25Q. 
 
3.4.4 Proteolytic digestion 
    To investigate the structure of the N17 region by HDX, efficient proteolytic digestion is 
essential. Three protease combinations were tested. Although pepsin digested Httex1 to 
a level where no intact protein was observed in the digestion profile, it only gave a 
collection of highly charged and lengthy peptides (Figure 3.9a). Both 50% and 100% 
protease XIII provided smaller peptides with a sacrifice of incomplete digestion (Figure 
3.9b-c). The digestion profile from 100% protease XIII had a higher sequence coverage 
and more peptides in the N17 region (Figure 3.9d). Peptides were identified using the 
unique sequence of Httex1. 
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Figure 3.9. Digestion efficiency of various proteases on HD16Q. 
The digested profiles of HD16Q were generated by (a) 100% pepsin, (b) 50:50 
pepsin:protease XIII mixture, or (c) 100% protease XIII. For easier comparison, (d) 
peptides from both protease XIII digestions were colour mapped together. Each bar 
represents a peptide with a corresponding sequence aligned on top. The 50:50 
pepsin:protease XIII mixture produced 83% sequence coverage, while 100% protease 
XIII gave a slightly higher sequence coverage of 89%. 
 
3.5 Conclusion 
    The purification and tag removal of the Httex1 constructs with a short polyQ expansion 
was successful. The disordered structure of Httex1 is well-represented by a wide charge 
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distribution in native ESI MS. A more compact structure is associated with a longer polyQ 
(HD25Q) below the pathological length. However, the purification of tag-free Httex1 with 
longer polyQ lengths requires more optimization. Recently, Reif et al. have purified tag-
free HD43Q. In their protocol, Httex1 is purified with reverse phase HPLC and lyophilized 
immediately after tag removal.139 However, Httex1 has transient secondary structure 
despite being an intrinsically disordered protein. Httex1 loses its structural information 
after exposure to organic solvent and low pH in the reverse phase column. “Softer” 
methods are still required in order to study native Httex1 properties after tag removal and 
before visible aggregation. 
    The switch between asymptomatic and diseased phenotypes at a critical polyQ length 
remains a mystery. Although an acute change of structure after 39 glutamine residues 
has long been the hypothesis, Warner et al. showed that normal and mutant Httex1 has 
similar tadpole structures via fluorescence resonance energy transfer and simulations.140 
Assuming correct modelling, the physiological to pathological switch of Htt may come 
from the higher fragmentation tendency of longer polyQs. A higher N terminal fragment 
concentration from a more cleavage-prone mutant Htt unavoidably facilitates aggregation. 
Both theories have failed to explain the link between age onset and polyQ length. More 
studies on the molecular pathology of Htt function or dysfunction are needed before an 
effective therapy can be explored. 
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Chapter Four: Conclusion and Future Work 
4.1 Conclusion 
    This work applied various MS methods to study protein-ligand and protein-protein 
interactions. In chapter 2, the complexes of Lcn2 with three of its ligands, ferric 2,3-DHBA, 
ferric Ent and Ent, were investigated. The results showed that Lcn2 is able to discriminate 
between ligands and form complexes with different stabilities, although all ligands 
ultimately unfold the protein. The variations between complexes may distinguish the 
intracellular releasing mechanism of Lcn2. The MS-based analysis provides structural 
evidence for different intracellular effects and releasing rates indirectly. In chapter 3, the 
self-interaction of polyQ proteins leads to aggregation. Httex1 constructs with a polyQ 
above pathological length were shown to aggregate faster at similar or even lower 
concentrations compared to its physiological variants. Conceivably, the longer polyQ 
changes the protein structure or the way Httex1 interacts with each other. 
 
4.2 Future Work 
    Chapter 2 studies the binding of siderophores to Lcn2, but the releasing mechanism of 
these ligands is puzzling. It is commonly believed that the low pH (6.5-4.5) conditions of 
the endosome and lysosome protonates siderophores and promotes their release.141 
However, we observe a majority of folded protein and intact complexes with Lcn2 and 
siderophores at pH 2.5. This raises questions regarding the intracellular release of 
siderophores. Since Lcn2 is proposed to recycle, Lcn2 cannot be destroyed by the 
lysosome if this theory held true.70 In turn, the transfer of iron to another molecule is more 
likely. Heme proteins, iron-binding proteins, and vitamin C can be used to probe this 
transfer.142 With the incubation of natural intracellular iron chelators with iron-loaded Lcn2 
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at cytosol or endosomal pH, the transfer of iron can be monitored by native ESI MS if 
present. Understanding this iron-releasing mechanism can be important in resolving the 
transportation of excess iron into mitochondria for ROS accumulation. 
    The most pronounced challenge encountered in Chapter 3 is that Httex1 with longer 
polyQs form aggregates before any meaningful analysis could be performed. To address 
that, reverse phase chromatography and lyophilisation are utilized to prevent aggregation. 
However, the aggregation will continue once Httex1 is in solution again. A better method 
would be to perform online cleavage of the tag and monitor the aggregation immediately. 
The enzymatic activity of EK is much weaker but still functional in NH4Ac (Appendix 3). 
Native mass spectra can be acquired at different time points of the incubation. Due to the 
distinct masses of various species (EK, TrxA, TrxA-Httex1, and Httex1), the tag-free 
Httex1 should be easily identified. Utilizing the power of IMS, the monomer and oligomers 
can be separated and monitored as well. As a diploid species, Httex1 almost always exists 
in heterogeneity in humans. A more interesting question would be whether a normal 
Httex1 could slow down the aggregation of a mutant. A similar online monitoring system 
with a mixture of species might be able to provide this information. 
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Appendices 
 
Appendix 1: Cell-based assay for intracellular ROS accumulation. 
The accumulation of intracellular ROS was tested in H9C2 cells. (a) The ROS fold 
changes with limited iron in the complete growth media were monitored in a dose-
dependent manner. (b) Supplementary Fe3+ at a 1:1 or 3:1 siderophore:iron ratio 
increased the ROS responses. 
 
 
 
 
Appendix 2: Sequence of TrxA-HD16Q. 
The sequence of the TrxA tag is highlighted in orange. DDDKX is the recognition site for 
enterokinase, which cleaves immediately after K. The six histidines at the C terminus of 
the sequence is un-removable. TrxA-HD16Q is shown as an example because the only 
difference between the four constructs is the length of glutamine. 
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Appendix 3: Full-chain EK cleaved TrxA-HD16Q in 500mM NH4Ac. 
After 4hrs of incubation at RT with 1.5 IU/mg full-chain EK, (a) TrxA-HD16Q was partially 
digested into (b) HD16Q. The most intense peak in the in HD16Q was the 7+ charge state. 
Although more than one species was present in the cleaved product, the tag-free protein 
was clearly identifiable. 
 
